Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1525 | 7477 | 41.0 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
494 | 3 | AVIAN DISEASES//AVIAN PATHOLOGY//NEWCASTLE DISEASE VIRUS | 22905 |
1525 | 2 | ADJUVANT//ISCOM//VACCINE | 7477 |
3572 | 1 | CHOLERA TOXIN//HEAT LABILE ENTEROTOXIN//MUCOSAL ADJUVANT | 1955 |
5170 | 1 | VACCINE DELIVERY//ADJUVANT//ANTIGEN DELIVERY | 1662 |
13376 | 1 | B CELL EPITOPE PREDICTION//PREDETERMINED SPECIFICITY//SYNTHETIC ANTIGENIC SITE | 841 |
14411 | 1 | ISCOM//QUIL A//QUILLAJA SAPONARIA MOLINA | 771 |
17047 | 1 | ALUMINUM HYDROXIDE ADJUVANT//ALUMINUM CONTAINING ADJUVANTS//MACROPHAGIC MYOFASCIITIS | 620 |
17280 | 1 | LIPOAMINO ACIDS//LIPOPEPTIDE//LIPIDIC AMINO ACID | 607 |
19461 | 1 | LIPOSOMAL ANTIGENS//DRUG DELIVERY SYST DEV//FUSOGENIC LIPIDS | 504 |
22255 | 1 | GRP PEPTIDE CHEM//PEPTIDE PROT CHEM//PHYSICOCHEM UNIT | 388 |
33088 | 1 | VIROSOMES//FUSOGENIC LIPOSOME//FRAGMENT A OF DIPHTHERIA TOXIN | 129 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADJUVANT | authKW | 530064 | 11% | 17% | 788 |
2 | ISCOM | authKW | 270261 | 1% | 66% | 100 |
3 | VACCINE | journal | 173333 | 12% | 5% | 876 |
4 | CHOLERA TOXIN | authKW | 136902 | 2% | 19% | 180 |
5 | VACCINE DELIVERY | authKW | 124242 | 1% | 34% | 89 |
6 | VACCINE ADJUVANT | authKW | 123619 | 1% | 35% | 86 |
7 | ANTIGEN DELIVERY | authKW | 121716 | 1% | 45% | 66 |
8 | MUCOSAL ADJUVANT | authKW | 119411 | 1% | 49% | 60 |
9 | HEAT LABILE ENTEROTOXIN | authKW | 104594 | 1% | 57% | 45 |
10 | IMMUNOBIOL VACCINE | address | 93663 | 1% | 43% | 54 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 57450 | 42% | 0% | 3156 |
2 | Medicine, Research & Experimental | 11728 | 16% | 0% | 1167 |
3 | Pharmacology & Pharmacy | 4236 | 16% | 0% | 1200 |
4 | Infectious Diseases | 2307 | 6% | 0% | 446 |
5 | Biochemistry & Molecular Biology | 1886 | 17% | 0% | 1294 |
6 | Materials Science, Biomaterials | 1616 | 3% | 0% | 200 |
7 | Biochemical Research Methods | 1202 | 5% | 0% | 386 |
8 | Virology | 707 | 3% | 0% | 214 |
9 | Chemistry, Medicinal | 660 | 4% | 0% | 266 |
10 | Microbiology | 571 | 5% | 0% | 384 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOBIOL VACCINE | 93663 | 1% | 43% | 54 |
2 | GRP PEPTIDE CHEM | 63719 | 1% | 24% | 64 |
3 | PEPTIDE PROT CHEM | 42291 | 0% | 31% | 33 |
4 | PHYSICOCHEM UNIT | 30055 | 0% | 82% | 9 |
5 | AK TUMORIMMUNOL VAKZINE | 25000 | 0% | 88% | 7 |
6 | ADJUVANT UNIT | 24492 | 0% | 100% | 6 |
7 | PLA BIOPHARMACEUT PROD FORMULAT ENGN | 19441 | 0% | 53% | 9 |
8 | DRUG DELIVERY TECHNOL | 19175 | 0% | 13% | 36 |
9 | PROD 1 | 18178 | 0% | 64% | 7 |
10 | SAFETY BLOOD BIOL PROD | 17615 | 0% | 21% | 21 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 173333 | 12% | 5% | 876 |
2 | JOURNAL OF CONTROLLED RELEASE | 12784 | 2% | 2% | 154 |
3 | EXPERT REVIEW OF VACCINES | 10192 | 1% | 5% | 56 |
4 | INFECTION AND IMMUNITY | 8493 | 3% | 1% | 240 |
5 | MOLECULAR IMMUNOLOGY | 7887 | 2% | 2% | 118 |
6 | JOURNAL OF IMMUNOLOGICAL METHODS | 5794 | 2% | 1% | 119 |
7 | IMMUNOLOGY | 5559 | 1% | 1% | 111 |
8 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 4961 | 2% | 1% | 142 |
9 | IMMUNOLOGICAL COMMUNICATIONS | 4786 | 0% | 7% | 16 |
10 | ADVANCED DRUG DELIVERY REVIEWS | 4358 | 1% | 2% | 54 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADJUVANT | 530064 | 11% | 17% | 788 | Search ADJUVANT | Search ADJUVANT |
2 | ISCOM | 270261 | 1% | 66% | 100 | Search ISCOM | Search ISCOM |
3 | CHOLERA TOXIN | 136902 | 2% | 19% | 180 | Search CHOLERA+TOXIN | Search CHOLERA+TOXIN |
4 | VACCINE DELIVERY | 124242 | 1% | 34% | 89 | Search VACCINE+DELIVERY | Search VACCINE+DELIVERY |
5 | VACCINE ADJUVANT | 123619 | 1% | 35% | 86 | Search VACCINE+ADJUVANT | Search VACCINE+ADJUVANT |
6 | ANTIGEN DELIVERY | 121716 | 1% | 45% | 66 | Search ANTIGEN+DELIVERY | Search ANTIGEN+DELIVERY |
7 | MUCOSAL ADJUVANT | 119411 | 1% | 49% | 60 | Search MUCOSAL+ADJUVANT | Search MUCOSAL+ADJUVANT |
8 | VACCINE | 111691 | 9% | 4% | 692 | Search VACCINE | Search VACCINE |
9 | HEAT LABILE ENTEROTOXIN | 104594 | 1% | 57% | 45 | Search HEAT+LABILE+ENTEROTOXIN | Search HEAT+LABILE+ENTEROTOXIN |
10 | ALUMINUM HYDROXIDE ADJUVANT | 83047 | 0% | 88% | 23 | Search ALUMINUM+HYDROXIDE+ADJUVANT | Search ALUMINUM+HYDROXIDE+ADJUVANT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE HAAN, L , HIRST, TR , (2000) CHOLERA TOXIN AND RELATED ENTEROTOXINS: A CELL BIOLOGICAL AND IMMUNOLOGICAL PERSPECTIVE.JOURNAL OF NATURAL TOXINS. VOL. 9. ISSUE 3. P. 281 -297 | 111 | 94% | 13 |
2 | SHARMA, S , MUKKUR, TKS , BENSON, HAE , CHEN, Y , (2009) PHARMACEUTICAL ASPECTS OF INTRANASAL DELIVERY OF VACCINES USING PARTICULATE SYSTEMS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 98. ISSUE 3. P. 812-843 | 119 | 56% | 69 |
3 | IRVINE, DJ , HANSON, MC , RAKHRA, K , TOKATLIAN, T , (2015) SYNTHETIC NANOPARTICLES FOR VACCINES AND IMMUNOTHERAPY.CHEMICAL REVIEWS. VOL. 115. ISSUE 19. P. 11109 -11146 | 111 | 33% | 52 |
4 | WANG, SJ , LIU, HQ , ZHANG, XY , QIAN, F , (2015) INTRANASAL AND ORAL VACCINATION WITH PROTEIN-BASED ANTIGENS: ADVANTAGES, CHALLENGES AND FORMULATION STRATEGIES.PROTEIN & CELL. VOL. 6. ISSUE 7. P. 480 -503 | 119 | 49% | 3 |
5 | ZHAO, L , SETH, A , WIBOWO, N , ZHAO, CX , MITTER, N , YU, CZ , MIDDELBERG, APJ , (2014) NANOPARTICLE VACCINES.VACCINE. VOL. 32. ISSUE 3. P. 327 -337 | 78 | 42% | 123 |
6 | CONNELL, TD , (2007) CHOLERA TOXIN, LT-I, LT-IIA AND LT-IIB: THE CRITICAL ROLE OF GANGLIOSIDE BINDING IN IMMUNOMODULATION BY TYPE I AND TYPE II HEAT-LABILE ENTEROTOXINS.EXPERT REVIEW OF VACCINES. VOL. 6. ISSUE 5. P. 821 -834 | 90 | 70% | 30 |
7 | SILVA, AL , SOEMA, PC , SLUTTER, B , OSSENDORP, F , JISKOOT, W , (2016) PLGA PARTICULATE DELIVERY SYSTEMS FOR SUBUNIT VACCINES: LINKING PARTICLE PROPERTIES TO IMMUNOGENICITY.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 12. ISSUE 4. P. 1056 -1069 | 73 | 68% | 0 |
8 | ALLAHYARI, M , MOHIT, E , (2016) PEPTIDE/PROTEIN VACCINE DELIVERY SYSTEM BASED ON PLGA PARTICLES.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 12. ISSUE 3. P. 806 -828 | 75 | 60% | 1 |
9 | FERREIRA, SA , GAMA, FM , VILANOVA, M , (2013) POLYMERIC NANOGELS AS VACCINE DELIVERY SYSTEMS.NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. VOL. 9. ISSUE 2. P. 159-173 | 80 | 56% | 24 |
10 | HAJISHENGALLIS, G , ARCE, S , GOCKEL, CM , CONNELL, TD , RUSSELL, MW , (2005) IMMUNOMODULATION WITH ENTEROTOXINS FOR THE GENERATION OF SECRETORY IMMUNITY OR TOLERANCE: APPLICATIONS FOR ORAL INFECTIONS.JOURNAL OF DENTAL RESEARCH. VOL. 84. ISSUE 12. P. 1104 -1116 | 92 | 64% | 45 |
Classes with closest relation at Level 2 |